Cardiac MRI measures as surrogate outcome for heart failure and atrial fibrillation: a Mendelian randomization analysis

AF Schmidt, C Finan, J van Setten, E Puyol-Anton… - medRxiv, 2022 - medrxiv.org
Background drug development and disease prevention of heart failure (HF) and atrial
fibrillation (AF) are impeded by a lack of robust early-stage surrogates. We determined to …

[HTML][HTML] Cardiac MRI to guide heart failure and atrial fibrillation drug discovery: a Mendelian randomization analysis

A Schmidt, C Finan, M Bourfiss, B Velthuis… - Research …, 2023 - ncbi.nlm.nih.gov
Background drug development and disease prevention of heart failure (HF) and atrial
fibrillation (AF) are impeded by a lack of robust early-stage surrogates. We determined to …